AGENUS INC — Director's Dealing 2010

Mar 18, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-03-16

Reporting Person: Valentine Karen (VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-16	Common Stock	S	29039	$0.7578	Disposed	51491	Direct

Footnotes

F1: The reported transaction was executed at sales prices ranging from $0.7510 to $0.7714. The reporting person undertakes to provide, upon the request by the SEC staff, Antigenics Inc. or any stockholder of Antigenics Inc., the full information regarding the number of shares sold at each separate price.